Drugs / URG101
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02591199 | Sep 2015 → May 2018 | interstitial cystitis | Urigen | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT00517868 | Aug 2007 → Feb 2008 | interstitial cystitis | Urigen | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | URG101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00517868 ↗ |
| Route | Other | “will receive a single administration of one of four intravesical treatments in a blinded fashion” NCT02591199 ↗ |